<DOC>
	<DOCNO>NCT03000023</DOCNO>
	<brief_summary>The study qualitative quantitative , gather patient 's perception HCV treatment benefit HCV treatment administer survey conduct in-depth qualitative patient interview . The study seek understand anticipate actual benefit patient perceive viral eradication .</brief_summary>
	<brief_title>Anticipated Perceived Benefits Following Hepatitis C Treatment</brief_title>
	<detailed_description>This study employ mixed method ( qualitative quantitative ) pre-post study design utilize in-depth qualitative interview patient report outcome survey . Pre-treatment survey interview conduct HCV therapy commences understand potential psychological , social , physical medical consequence perceive related HCV patient ' anticipation ( hope ) improvement factor viral eradication . Post-treatment survey interview occur 4 8 month treatment end examine long-term treatment benefit , i.e. , change HCV-related factor , symptom , function , health status .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Age 21 old Englishspeaking Any genotype Any treatment duration ( e.g . 8 , 12 , 24 week ) Has write prescription sofosbuvir ( SOF ) contain regimen . Currently list liver transplant ; postliver transplant</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Patient-Reported Outcomes</keyword>
	<keyword>DAA Treatment</keyword>
	<keyword>Qualitative</keyword>
	<keyword>Mixed method</keyword>
</DOC>